Clinical outcomes
Clinical outcomes are measurable consequences of a disease, intervention, diagnostic strategy, or care pathway in patients.
Clinical outcomes are measurable consequences of a disease, intervention, diagnostic strategy, or care pathway in patients. They may include survival and all-cause mortality, disease progression, complications, adverse events, hospital length of stay, functional status, and quality of life. Depending on the clinical setting, outcomes may be assessed over a short period—such as postoperative inflammation or inpatient recovery—or over longer intervals, such as progression-free survival and overall survival.
Clinical outcomes provide a patient-centered framework for evaluating medical care. They can be compared between treatments, used to identify prognostic factors, or predicted from demographic, clinical, molecular, and imaging data. Relevant variables in the associated literature include age, prognosis, C-reactive protein (CRP), inpatient care, and the Modified Rankin Scale. In computational medicine, clinical outcomes may also serve as target variables for artificial intelligence and machine-learning models that integrate information about diseases such as breast cancer, hepatocellular carcinoma, or pancreatic ductal adenocarcinoma.
Rebuilt from PubMed 18 Sept 2026 · no new papers today
Where the papers sit
11 papers study clinical outcomes directly. Those 11 do not group into themes. Prognostic associations, treatment outcomes, surgical techniques and study protocols span unrelated diseases and specialties. The set shares clinical-outcome reporting but has no common biological or therapeutic focus, so no direction emerges. They are no more alike than papers drawn from anywhere in the corpus.
Recent Findings on clinical outcomes
Cross-Specialty Outcome Assessment: Intratumoral PD-1+LAG-3+CD8+ T cells, treatment selection, operative technique, and disease severity shaped measured outcomes across these studies 42742874Sep42743142Sep42645621Aug42545873Aug. High PD-1+LAG-3+CD8+ T-cell infiltration predicted improved overall survival and pembrolizumab response, while piezosurgery and acupuncture combined with Jieyu Huoxue Formula improved postoperative or visual outcomes 42742874Sep42645621Aug42114798May. Preoperative biliary stenting instead increased bacterial contamination, postoperative inflammation, operative time, and wound dehiscence, while its other complications remained comparable 42668363Aug. Osteochondral autograft transplantation improved elbow range of motion and Timmerman-Andrews scores, but proximal radial-head migration independently predicted suboptimal outcomes; severe diabetic ketoacidosis increased ICU length of stay without clear mortality differences 42560067Aug42545873Aug. Prospective studies of ex vivo confocal microscopy and urokinase thrombolysis, together with pathMED machine learning, are extending clinical-outcome assessment toward diagnostic concordance, functional independence, cost-effectiveness, and cross-omics validation 42714336Sep42570202Aug42496598Jul.
Written from 11 PubMed abstracts, each one cited by PMID above. Published: 2026-09-10. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.